Skip to content

ARGA Investment Management, LP: RY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ARGA Investment Management, LP on RY, newest first. How the timeline and the estimate are built.

ARGA Investment Management, LP held 31,843 RY shares at 2026-06-30 per its 13F-HR filed 2026-07-31.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 31,843 shares
    Change vs previous 13F 0 shares

    0.17% of the 13F portfolio, value $6,594,785.

    13F-HR 0001104659-26-088902 filed by ARGA Investment Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 31,843 shares
    Change vs previous 13F 0 shares

    0.17% of the 13F portfolio, value $5,147,222.

    13F-HR 0001104659-26-052595 filed by ARGA Investment Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 31,843 shares
    Change vs previous 13F +159 shares

    0.15% of the 13F portfolio, value $5,428,012.

    13F-HR 0001104659-26-008316 filed by ARGA Investment Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 31,684 shares
    Change vs previous 13F 0 shares

    0.12% of the 13F portfolio, value $4,670,197.

    13F-HR 0001104659-25-104663 filed by ARGA Investment Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 31,684 shares
    Change vs previous 13F not available

    0.11% of the 13F portfolio, value $4,174,902.

    13F-HR 0001104659-25-072553 filed by ARGA Investment Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).